跳至主要内容
临床试验/JPRN-UMIN000045849
JPRN-UMIN000045849已完成未知

Study on the efficacy and safety of Remimazolam in one lung ventilation. - SEREV study

Kitasato University, School of Medicine, Department of Anesthesiology0 个研究点目标入组 70 人开始时间: 2021年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

An abstract of this study was presented at Euroanaesthesia 2023 (Glasgow, 2023). It has not yet been published as a paper and details will be published at the time of the paper's publication. There were no significant differences in oxygenation capacity at each time point. However, ephedrine use was significantly lower in the remimazolam group than in the propofol group.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • If the research subject refuses to cooperate in the research. Contraindications to the use of anesthetics. If the subject has a disease that affects HPV. In the case of a procedure in which one lung ventilation is frequently released intraoperatively, such as surgery for pneumothorax. Patients with longitudinal tumors in the supine position who may require only short periods of one-lung ventilation. If the patient is scheduled to receive intraoperative cardiopulmonary ventilation. Patients with severe chronic lung disease (1 sec rate 50%or less, % lung capacity less than 80%)

研究者

发起方
Kitasato University, School of Medicine, Department of Anesthesiology

相似试验